INSIGHTEC
Live / Applied — Fifth extension granted (statement of use) (as of 31 Dec 2025)
What this means for you
Not registered yet, but its 23 Jul 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90845233
- Mark type
- Word mark
- Filed
- 23 Jul 2021
- Published for opposition
- 15 Nov 2022
- Attorney of record
- Julia Anne Matheson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in disrupting the blood brain barrier for the treatment of neurological and oncological disease; pharmaceutical preparations for use in the treatment and diagnosis of neurological and oncological disease; pharmaceutical preparations for use with respect to ultrasound treatment and diagnosis of neurodegenerative disease and cancer
- Class 035 — Advertising and business services: Wholesale and retail distributorships featuring pharmaceuticals of others for use with ultrasound treatment and diagnosis in the fields of neurology, neurosurgery and oncology; wholesale and retail distributorships featuring pharmaceuticals for use with ultrasound treatment and diagnosis of neurodegenerative disease and cancer
Owner
- INSIGHTEC LTD., Tirat Carmel, IL
- INSIGHTEC LTD., Tirat Carmel, IL
Prior registrations
Prosecution history
- 01 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2025 — SOU EXTENSION 5 GRANTED
- 19 Aug 2025 — SOU EXTENSION 5 FILED
- 31 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2025 — SOU EXTENSION 4 GRANTED
- 20 Feb 2025 — SOU EXTENSION 4 FILED
- 20 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jul 2024 — SOU EXTENSION 3 GRANTED
- 29 Jul 2024 — SOU EXTENSION 3 FILED
- 29 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Feb 2024 — SOU EXTENSION 2 GRANTED